Search
for

    Research

    5 / 1000+ results
      Effective Medical Treatment for Common Baldness in Women

      research Effective medical treatment for common baldness in women

      43 citations , July 1984 in “Clinical and Experimental Dermatology”
      This study found that women with common baldness treated with cyclical antiandrogen therapy for 52 weeks experienced increased hair density and a higher percentage of hairs in the anagen growth phase.
      Regulation of Hair Growth

      research S127 Regulation of hair growth

      September 1997 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”
      The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.
      Anti-Androgen Therapy in Female Adult Acne

      research Anti-Androgen Therapy in Female Adult Acne

      4 citations , April 2016 in “Journal of Dermatology Research and Therapy”
      This article discusses the multifactorial nature of acne vulgaris, detailing its link to androgen-induced sebum production, altered keratinisation, inflammation, and bacterial colonisation, but reports no new research findings.

    Community Join

    2 / 1000+ results

      community Derm stopped me from using Minoxidal

      in Update  55 upvotes 10 months ago
      A dermatologist advised stopping minoxidil due to heavy shedding, suggesting alternative treatments like Betaval Lotion and supplements, but many users disagreed, recommending continuing minoxidil and adding finasteride for better results. The conversation highlights skepticism about the dermatologist's motives and emphasizes the importance of understanding the type of hair loss before choosing treatments.

      community 2 years fin only 1mg/daily + 4 months of gradually introducing Dut 0.5mg/daily

       1706 upvotes 1 year ago
      A user experienced significant hair regrowth using finasteride 1 mg daily for two years and gradually introduced dutasteride 0.5 mg daily over four months. They reported no side effects and plan to switch fully to dutasteride due to its cost-effectiveness and potential effectiveness.

    Learn

    5 / 801 results

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor
      • Is cyproterone safe to use during gender transition? Regulators and a large French cohort study link higher-dose, long-term cyproterone acetate to meningioma, and its label also lists liver-enzyme and mood effects — so it is not a drug anyone should call safe in the abstract, and its use in gender-affirming care is a prescriber's decision with monitoring.

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors
      • Can I use clascoterone if I'm undergoing gender-affirming hormone therapy? No published clinical trial has tested clascoterone in people on gender-affirming hormone therapy, so its safety in that group is unknown. The FDA label reports low systemic exposure and no described effect on blood testosterone, but it also records HPA-axis suppression and raised potassium in a small minority of subjects.

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen